Skip to main content

MASS LITIGATION ORDERS

The table below contains Mass Litigation Orders posted for the convenience of users.  To use the table, choose an Order Type or Mass Litigation Type from the drop list, then type in the search box, or sort by file date.  The file date is set to descending (most recent) by default.

File Date Title Mass Litigation Type County/Case No
09/12/2022 Joint Trial Exhibit Disclosure Order Opioid - Pharmacy Kanawha 21-C-9000 PHARM
09/08/2022 Refusal Order, State ex rel. CVS Pharmacy, Inc. v. Moats, Supreme Court No. 22-635 Supreme Court 22-635
09/08/2022 Order Regarding Joint Motion for Modification of the Order Establishing Procedure for Designation and Use of Deposition and Trial Testimony at Trial Opioid - Pharmacy Kanawha 21-C-9000 PHARM
09/08/2022 Order Regarding Motions for Summary Judgment, Motions to Exclude Expert Testimony, and Motions in Limine Opioid - Pharmacy Kanawha 21-C-9000 PHARM
08/30/2022 Order Affirming Discovery Commissioner's August 9, 2022, Order Opioid - Pharmacy Kanawha 21-C-9000 PHARM
08/30/2022 Partial Dismissal Order – Mallinckrodt plc, Mallinckrodt LLC, Mallinckrodt Brand Pharmaceuticals, Inc., Mallinckrodt Enterprises LLC, SpecGX LLC Opioid Kanawha 19-C-9000
08/23/2022 Order Denying Plaintiff's Motion to Strike Pharmacy Defendants' Hybrid Fact-Expert Witness Disclosures for Failure to Comply with Case Management Order Opioid - Pharmacy Kanawha 21-C-9000 PHARM
08/23/2022 Order Affirming Discovery Commissioner's August 4, 2022, order Opioid - Pharmacy Kanawha 21-C-9000 PHARM
08/23/2022 Order Denying Pharmacy Defendants' Motion to Strike Supplement to the Expert Report of Lacey Keller Opioid - Pharmacy Kanawha 21-C-9000 PHARM
08/20/2022 Order Establishing Procedure for Designation and Use of Deposition and Trial Testimony at Trial Opioid - Pharmacy Kanawha 21-C-9000 PHARM